FAS Launches Online Chemical Weapons Convention Archive to Mark 2nd Review Conference
FAS just launched an online compilation of more than 500 documents on the US ratification of the Chemical Weapons Convention (CWC). The Archive (/blog/cw) includes a timeline of CWC negotiations, a history of its signing and ratification, and current news and commentary on the CWC.
In addition to the documents, Cheryl Vos, FAS Biology Research Associate, will report daily from The Hague during the Second Review Conference, 7 – 18 April 2008, on the proceedings, plenary sessions and open forum.
The online archive’s “Document of the Day” feature will kick off with a letter submitted by former Secretary of Defense and current Vice President Dick Cheney to the Senate Foreign Relations Committee. The letter expresses Cheney’s deep opposition to U.S. ratification of the Chemical Weapons Convention and was read into the record by former Secretary of Defense James Schlesinger who, along with fellow former Secretaries of Defense Donald Rumsfeld and Caspar Weinberger, was present at the Committee hearing to provide testimony against the CWC. /cw/cwc_archive/cheneyletter_4-8-97.pdf
The CWC entered into force on April 29, 1997. The archive highlights accomplishments over the past 11 years, and arguments made for and against US ratification in Congress.
Many of the letters, petitions and reports have not been previously available online.
Visit the Chemical Weapons Convention Archive at /blog/cw/.
Given the unreliability of private market funding for agricultural biotechnology R&D, substantial federal funding through research programs such as AgARDA is vital for accelerating R&D.
“Given the number of existential crises we must collectively confront, I have found policy entrepreneurship to be a fruitful avenue towards doing some of that work.”
Outdated Bureau of Labor Statistics classifications hampers the federal government’s ability to design and implement effective policies for emerging technologies sectors.
Establishing an NIH Office of Infection-Associated Chronic Illness Research can guard against the long-term effects of Covid and lead to novel breakthroughs across many less understood diseases.